Selection of projects according to criteria:
Project status:
Project type:
Project leader:
PhoBioS – Understanding interaction light – biological surfaces: possibility for new electronic materials and devices
Pochopenie interakcie svetlo – biologické povrchy: možnosti pre nové elektronické materiály a zariadenia
Program: COST
Project ID: COST CA 21159
Duration: 19.10.2022 – 18.10.2026
Project leader: RNDr. Hain Miroslav, PhD.
Annotation: It is known that various biological surfaces are covered with micro- and nano-structures that perform a variety of functions (e.g., anti-reflective, structural coloration, anti-fouling, pro- or anti-adhesion …) and inspire us to many industrial applications. In recent years, there has been a significant upsurge of research in this field. The main objective of the COST Action "Understanding light-biological surface interactions: opportunities for new electronic materials and devices" is to bring together scientists coming from different disciplines in this lively area of research, focusing on the photonic effects of nano- and micro-structures of biological surfaces and their bionic applications. The consortium will ensure cross-inspiration between participants coming from different research fields and foster research innovation and possible industrial development.
Project website:
DYNALIFE – Information, Coding, and Biological Function: the Dynamics of Life
Informácia, kódovanie a biologická funkcia:Dynamika života
Program: COST
Project ID: CA21169
Duration: 11.1.2023 – 18.9.2026
Project leader: Mgr. Chvosteková Martina, PhD.
ReHaB – Towards an ecologically valid symbiosis of BCI and head-mounted VR displays: focus on collaborative post-stroke neurorehabilitation
Smerovanie k spoľahlivej a uživateľsky prijateľnej symbióze BCI a VR: zameranie na kolaboratívnu neurorehabilitáciu po cievnej mozgovej príhode
Program: ERANET
Project ID: ERA-net CHIST ERA IV
Duration: 1.1.2022 – 31.12.2024
Project leader: Ing. Mgr. Rosipal Roman, DrSc.
Annotation: A growing body of evidence suggests that integrated technologies of brain-computer interfaces (BCI) and virtual reality (VR) environments provide a flexible platform for a series of neurorehabilitation therapies, including significant post-stroke motor recovery and cognitive-behavioral therapy. When immersed in such an environment, the subject\’s perceptual level of social interaction is often impaired due to the sub-optimal quality of the interface lacking the social aspect of human interactions.The project proposes a user-friendly wearable low-power smart BCI system with an ecologically valid VR environment in which both the patient and therapist collaboratively interact via their person-specific avatar representations. On the one hand, the patient voluntarily, and in a self-paced manner, manages their activity in the environment and interacts with the therapist via a BCI-driven mental imagery process. This process is computed and rendered in real-time on an energy-efficient wearable device. On the other hand, the therapist\’s unlimited motor and communication skills allow him to fully control the environment. Thus, the VR environment may be flexibly modified by the therapist allowing for different occupational therapy scenarios to be created and selected following the patient\’s recovery needs, mental states, and instantaneous responses.
The technologically undemanding of aluminate glasses with interested optical properties
Technologicky nenáročná príprava hlinitanových skiel so zaujímavými optickými valstnosťami
Program: Open Mobility
Project ID: Open-Mob-2022-06
Duration: 1.1.2023 – 31.12.2024
Project leader: Ing. Majerová Melinda, PhD.
PARQ – Sudden cardiac arrest prediction and resuscitation network: Improving the quality of care
Predikcia náhlej srdcovej zástavy a systém resuscitácie: Zvýšenie kvality zdravotnej starostlivosti
Program: COST
Project ID: CA19137
Duration: 26.10.2020 – 25.10.2024
Project leader: Ing. Švehlíková Jana, PhD.
Annotation: Sudden cardiac arrest (SCA) causes 2 million deaths each year in Europe alone. Since SCA strikes unexpectedly and is lethal within minutes if untreated, solving this problem requires (1) recognizing individuals at risk and designing preventive strategies, (2) providing timely and effective treatment. Because SCA mostly occurs out-of-hospital, SCA victims rely on first-response treatment provided by citizens, firefighters and emergency medical services. There are large regional differences in SCA survival rates across Europe (1-30%). This suggests that regional differences in individual risk prediction, prevention and treatment have a major impact on the chance to survive. To improve survival rates across Europe it is imperative to study: 1) inherited, acquired, and environmental risk factors of SCA across European regions; 2) regional differences in preventive measures and first-response treatment strategies and their effectiveness. The PARQ Action will facilitate this research by forming a pan-European network of excellence in SCA and resuscitation science. This network includes investigators from different disciplines including cardiology, molecular biology, resuscitation science, emergency medicine, general practice and health economics. The main objectives of the Action are to promote development of standards for collection of clinical data and biological samples and to harmonize data analysis. This will aid in development of risk prediction models based on inherited, acquired and environmental risks. The PARQ action will focus on European differences in first-response treatment and develop guidelines. In summary, the PARQ Action investigators will enable breakthrough developments to decrease the incidence of SCA and improve survival, while reducing the vast regional European differences in survival rates.
Project website: